81 |
Office Management of Cervical Intraepithelial NeoplasiaHolmes, Sheri, Olsen, Martin E. 01 January 2016 (has links)
No description available.
|
82 |
Measurement of Mast Cell Cytokine Release by Multiplex AssayBreuel, Kevin, De Ponti, W. Keith 01 January 2006 (has links)
Mast cells are highly responsive cells that are capable of secreting a variety of inflammatory mediators, including histamine, heparin, serine proteases, leukotrienes, prostaglandins, and thromboxanes. Studies from several laboratories have demonstrated that mast cells have the capacity to produce a variety of cytokines in response to various stimuli. Characterization of the cytokine profiles in mast cells has routinely been determined by the performance of individual enzyme-linked immunosorbent assays. This process is expensive, time-consuming, and requires a great deal of material to characterize multiple cytokines. In this chapter, we describe a multiplex cytokine assay to detect 17 cytokines simultaneously in 50 microL of culture supernatant derived from stimulated human cord blood-derived mast cells.
|
83 |
Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious ChallengeRice, Peter J., Adams, Elizabeth L., Ozment-Skelton, Tammy, Gonzalez, Andres J., Goldman, Matthew P., Lockhart, Brent E., Barker, Luke A., Breuel, Kevin F., DePonti, Warren K., Kalbfleisch, John H., Ensley, Harry E., Brown, Gordon D., Gordon, Siamon, Williams, David L. 01 September 2005 (has links)
Glucans are immunomodulatory carbohydrates found in the cell walls of fungi and certain bacteria. We examined the pharmacokinetics of three water-soluble glucans (glucan phosphate, laminarin, and scleroglucan) after oral administration of 1 mg/kg doses in rats. Maximum plasma concentrations for glucan phosphate occurred at 4 h. In contrast, laminarin and scleroglucan showed two plasma peaks between 0.5 and 12 h. At 24 h, 27 ± 3% of the glucan phosphate and 20 ± 7% of the laminarin remained in the serum. Scleroglucan was rapidly absorbed and eliminated. The liver did not significantly contribute to the clearance of plasma glucan. Biological effects were further studied in mice. Following oral administration of 1 mg, glucans were bound and internalized by intestinal epithelial cells and gut-associated lymphoid tissue (GALT) cells. Internalization of glucan by intestinal epithelial cells was not Dectindependent. GALT expression of Dectin-1 and toll-like receptor (TLR) 2, but not TLR4, increased following oral administration of glucan. Oral glucan increased systemic levels of interleukin (IL)-12 (151 ± 15%) in mice. Oral glucan administration also increased survival in mice challenged with Staphylococcus aureus or Candida albicans. These data demonstrate that orally administered water-soluble glucans translocate from the gastrointestinal (GI) tract into the systemic circulation. The glucans are bound by GI epithelial and GALT cells, and they modulate the expression of pattern recognition receptors in the GALT, increase IL-12 expression, and induce protection against infectious challenge.
|
84 |
Rural Health in Iraqi KurdistanMyers, Wayne, Behringer, Bruce, Olsen, Martin 01 January 2005 (has links)
No description available.
|
85 |
Type I von Willebrand's Disease Presenting as Recurrent Corpus HemorrhagicumJarvis, Raymond R., Olsen, Martin E. 07 May 2002 (has links)
BACKGROUND: Female patients with undiagnosed von Willebrand's disease may present with heavy menorrhagia. This is a case report of a patient with undiagnosed von Willebrand's disease presenting with recurrent corpus hemorrhagicum. CASE: A nulliparous woman presented with her second episode of hemoperitoneum secondary to a ruptured corpus hemorrhagicum. CONCLUSION: Patients with recurrent corpus hemorrhagicum may be at risk for von Willebrand's disease even if no history of menorrhagia or bleeding disorder exists.
|
86 |
A Practical Treatise on Midwifery Containing the Result of 16,654 Births Occurring in the Dublin Lying-in Hospital During a Period of Seven Years Commencing November 1826Olsen, Martin E. 01 November 2001 (has links)
No description available.
|
87 |
Infertility-Related SurgeriesRansom, Mark X. 15 February 2018 (has links)
No description available.
|
88 |
Physicians and Healthcare SystemsOlsen, Martin E. 15 February 2018 (has links)
No description available.
|
89 |
Healthcare of Lesbian, Bisexual, and Transgender PatientsOlsen, Martin E. 15 February 2018 (has links)
No description available.
|
90 |
OncofertilityRansom, Mark X. 15 February 2018 (has links)
No description available.
|
Page generated in 0.0624 seconds